3657 results for «445»
3657 results
Meaningful innovations in interventional cardiology
18 May 2023 – From EuroPCR 2023
In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!
Redo-TAVI and patient pathway optimisation - Lifetime management decisions today for challenges of the future!
18 May 2023 – From EuroPCR 2023
Watch this session if you want to learn more about the BENCHMARK Registry and its key findings, explore how patients can benefit from optimised TAVI programmes, get an idea of how challenging Redo-TAVI will be for everyday practice in the future, and to view a LIVE...
DCB and scaffolds
16 May 2023 – From EuroPCR 2023
Watch this session to learn about 4 cases, including a patient who underwent successful PTCA with BRS on LAD using the PSP technique, and discuss the best option to consider when choosing between DEB and stents in tricky situations and individual patients.
Contemporary best clinical practice for TAVI
18 May 2023 – From EuroPCR 2023
This interactive session is designed to show how a good pre-procedural assessment can facilitate the planning of a procedure. It also shows how a certain valve can be best suited for patients with certain phenotypes, and finally how to fully optimise the procedure to obtain the...
Complex vascular access for TAVI procedure
16 May 2023 – From EuroPCR 2023
“Application of peripheral endovascular technology in TAVI”, “TAVI with novel device, concomitant aortic aneurysm repair and outcomes”, “Path for glory is calcified and tortuous” are a few of the cases featured in this session. Tune in to gain a comprehensive insight into effective management strategies for...
Left main and complex bifurcation stenting
18 May 2023 – From EuroPCR 2023
Want more training on bifurcation stenting? Learn from the case of this 75-year-old active man, a retired engineer, suffering from effort angina CCS 3 for 6 months, referred to the centre by his cardiologist for a coronary CT scan. He is a former smoker, has a...
Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)
18 May 2023 – From EuroPCR 2023
Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.
More pulses to take you further across all calcium morphologies
17 May 2023 – From EuroPCR 2023
Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!
Elixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function
09 May 2023
EuroPCR 2025: Late-breaking data demonstrate sustained significantly lower event rates with Elixir Medical’s DynamX® Bioadaptor over drug-eluting stent through three Years
21 May 2025
EuroPCR 2026: Elixir Medical's DynamX® bioadaptor demonstrates significantly lower event rates than drug-eluting stent in long-term follow-up, including reduction in cardiovascular death
19 May 2026
Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
03 Nov 2023
Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients
26 Sep 2025
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
27 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months
28 Oct 2024
EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years
14 May 2024
EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
17 May 2023